Send to a Friend Font Size: Increase Decrease

IVBIY and HCM Related Headlines

May 21, 2026 06:00AM Innovent and HUTCHMED Jointly Announce NMPA Approval for TYVYT® (Sintilimab Injection) in Combination with ELUNATE® (Fruquintinib) for the Treatment of Patients with Locally Advanced or Metastatic R

IVBIY and HCM Related Press Releases

May 21, 2026 06:00AM Innovent and HUTCHMED Jointly Announce NMPA Approval for TYVYT® (Sintilimab Injection) in Combination with ELUNATE® (Fruquintinib) for the Treatment of Patients with Locally Advanced or Metastatic R

IVBIY and HCM Related SEC Filings